Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Analysis of Historical Data on Hematological Remission and Survival Among Adult Patients With Relapsed / Refractory B-Precursor Acute Lymphoblastic Leukemia

NCT02003612 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02003612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02003612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Analysis of Historical Data on Hematological Remission and Survival Among Adult Patients With Relapsed / Refractory B-Precursor Acute Lymphoblastic Leukemia
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
October 1, 2013
Completion date
April 28, 2014
Enrollment
2,373 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia